6 May 2021: OIA response | Number of unique people dispensed emtricitabine with tenofovir disoproxil (PrEP) without other HIV antiretrovirals

6 May 2021

Dear [name and contact details withheld] 

REQUEST FOR INFORMATION

Thank you for your request dated 14 April 2021 under the Official Information Act 1982 (OIA) for information relating to emtricitabine with tenofovir dispoproxil (PrEP). You requested:

The number of unique people dispensed PrEP without other antiretrovirals, split by calendar year (2019, 2020)

Please find data for your request in the table below. 

Table: Number of unique people dispensed emtricitabine with tenofovir disoproxil without other HIV antiretrovirals

Funding DHB

2019   

2020

Auckland

1253

1421

Counties Manukau    

148

188

Waitemata

335

416

Total

1736

2025

Note:

  • The categorisation used here to identify relevant prescriptions is based on the specific request and is not PHARMAC's usual definition of PrEP patients.
  • This may mean that the data represents an over count of relevant prescriptions, as some people receiving emtricitabine with tenofovir disoproxil may at different times get these scripts with and without another antiretroviral.
  • Data provided is for the 2019 and 2020 calendar years.
  • People can be dispensed, and therefore counted, in multiple DHBs.
  • The "Funding DHB" is the DHB of dispensing. 

We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this. 

Yours sincerely

Rachel Read
Manager, Policy and Government Services